Get started
Author

Aseel O. Rataan

Observed names: Aseel O Rataan, Rataan, Aseel O., Rataan, Aseel Owayed Awad
Institution: Yarmouk University
ORCID: 0000-0001-9136-5504
Observed ORCID: 0000-0001-9136-5504
OpenAlex ID: A5081979682
Potential Role of Selenium in the Treatment of Cancer and Viral Infections
2022 · Aseel O. Rataan, Sean M. Geary, et al. · International Journal of Molecular Sciences · 68
PDF
MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets
2022 · Samuel Swearson, Aseel O. Rataan, et al. · International Journal of Molecular Sciences · 7
PDF
Knowledge and awareness of breast cancer signs and symptoms among Jordanian women
2025 · Amjad Z. Alrosan, Tahani Alwidyan, et al. · Future Science OA · 6
In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression
2025 · Yan Xu, Alexandra Mcmillan, et al. · Cancer Immunology Immunotherapy · 6
PDF
Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer
2025 · Haneen Amawi, Alaa M. Hammad, et al. · Cancer Biology and Medicine · 4
PDF
Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell Carcinoma
2025 · Yousef Zakharia, Ryan J. Reis, et al. · Clinical Cancer Research · 2
Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential
2024 · Aseel O. Rataan, Yan Xu, et al. · Cancer Treatment and Research Communications · 2
Understanding breast cancer causes: insights from Jordanian women’s awareness
2026 · Ghaith B. Heilat, Tahani Alwidyan, et al. · Future Science OA · 1
PDF
Comparative pharmacological analysis of fam-trastuzumab deruxtecan-nxki and sacituzumab govitecan-hziy: Two recently developed chemotherapies in the crucial battle against breast cancer
2025 · Amjad Z. Alrosan, Isra Dmour, et al. · Toxicology Reports · 1
Knowledge, attitudes and practices regarding immediate breast reconstruction after mastectomy: a cross-sectional study in Jordan
2026 · Aseel O Rataan, Mariam Alameri, et al. · BMJ Open
PDF
Pharmacologic doses of ascorbic acid and seleno-L-methionine are new and novel class of transforming growth factor-beta 1 inhibitor: mechanisms and therapeutic potential
2026 · Youcef M Rustum, Aseel O. Rataan, et al. · Medical Research Archives
Assessing the hepatic and renal parameters of breast cancer patient blood samples before and after chemotherapy
2026 · Ghaith B. Heilat, Tahani Alwidyan, et al. · Toxicology Reports
Understanding breast cancer causes: insights from Jordanian women’s awareness
2026 · Ghaith B. Heilat, Tahani Alwidyan, et al. · Figshare
Harnessing Oxidative Stress to Kill Hepatocellular Carcinoma Cancer Cells: The Power of Methylselenic Acid and/or Pharmacological Ascorbate Combination—An In Vitro Study
2026 · Aseel O. Rataan, Amjad Z. Alrosan, et al. · Advances in Pharmacological and Pharmaceutical Sciences
Modulating morphine-induced conditioned place preference: The role of diclofenac sodium
2025 · Haneen Amawi, Rawan Alhazaimeh, et al. · Toxicology Reports
Pre-treatment red cell index and metastasis status as independent predictors of overall survival in Jordanian breast cancer patients receiving chemotherapy
2025 · Amjad Z. Alrosan, Tahani Alwidyan, et al. · Toxicology Reports
Data from Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell Carcinoma
2025 · Yousef Zakharia, Ryan J. Reis, et al.
Supplementary Data1 from Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell Carcinoma
2025 · Yousef Zakharia, Ryan J. Reis, et al.
Supplementary Table 3 from Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell Carcinoma
2025 · Yousef Zakharia, Ryan J. Reis, et al.
Works count: 21
Citation count: 97
H-index: 4
I10-index: 1
Year
Topic
Type